Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Other Non-Current Liabilities of $1.3 million for Q4 2025, down 68.71% year-over-year from $4.1 million in Q4 2024, and down 1.98% quarter-over-quarter from $1.3 million in Q3 2025.
Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Non-Current Liabilities for 8 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 68.71% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (down 68.71% YoY), while the FY2025 annual figure was $1.2 million, down 70.8% from the prior year.
- Other Non-Current Liabilities retreated to $1.3 million in Q4 2025 per ACB's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $4.2 million in Q2 2022 and bottomed at $502106.4 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $2.7 million across 5 years, with a median of $2.9 million in 2022.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities jumped 774.11% — and 2025, when it slumped 71.71%.
- Aurora Cannabis' Other Non-Current Liabilities stood at $2.0 million in 2021, then soared by 30.46% to $2.6 million in 2022, then jumped by 48.7% to $3.8 million in 2023, then grew by 6.69% to $4.1 million in 2024, then slumped by 68.71% to $1.3 million in 2025.
- Business Quant data shows ACB's Other Non-Current Liabilities at $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.29 Mn |
| Dec 31, 2022 | 2.56 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 4.24 Mn |
| Mar 31, 2022 | 502,106.36 |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.69 Mn |
| Mar 31, 2021 | 1.58 Mn |